On May 26 and 27, Axinn partner David Silverstein participated in a video interview with Pharmacy Times on, "There Are ‘Definite Implications’ of White House Support for Waiving IP Protections of COVID-19 Vaccines" and "‘It’s Not the Vaccine IP That's the Real Barrier’ to Increasing COVID-19 Vaccine Access Abroad."

Click to access part 1 and part 2 of the interview.